ESGCT / SETGYC Annual Congress

93 days

0 hours

6 mins


Education Session
Tuesday 16 October 2018
Organiser: Hildegard Büning, MHH
09:15-09:30 Session Educ1
INV013 Hildegard Büning, Gene and cell therapy - a brief update
09:30-11:00 Educ 2: Tech. Speed Dating (15 minutes each and 15 for questions)
INV014 Els Verhoeyen - Retro- and lentiviral vector technology  
INV015 Karim Benihoud & INV013 Hildegard Büning - Novel lentiviral pseudotypes for natural killer based cancer immunotherapies and ‘nanoblades’ for efficient gene editing in T, B, iPS cells  and  blood stem cells 
INV016 Eduard Ayuso - Manufacturing and quality control of viral vectors
INV017 Claudio Mussolino - How to re-write or epigenetic control our genetic information 
INV018 Michel Pucéat - A brief overview on iPSC and embryonic stem cell technology
11:00- 11:30 COFFEE BREAK
11:30-12:30 Educ 3: Cancer – where do we stand and how to move forward?
INV019 Vincenzo Cerullo - Dressing viruses in tumor’s clothing: welcome to the cloning-free oncolytic vaccine era
INV020 Luigi Naldini - Lentiviral vectors: the first 20 years.
INV021 Delphine Fessart - Cancer stem cells and organoids development: towards a better understanding of the biology behind organoids
12:30-13:30 LUNCH
13:30-15:00 Educ 4: CNS Session
INV022 Nicole Déglon - Introduction to gene and cell therapy in the CNS
INV023 Nathalie Cartierv- Gene therapy for Huntington’s disease
INV024 Ron Crystal - Gene therapy for Alzheimer’s disease
15:00-16:30 Educ 5: HSC stem cells - where do we stand and how to move forward 
INV025 Adrian Thrasher - Primary immunodeficiency, GT vs. alternative strategies how do we move into the “real” clinical reality 
INV026 Juan Bueren  - Gene Therapy in Bone Marrow Failure Syndromes
INV027 Olivier Nègre - Haematopoietic stem cell gene therapy